TNF and allergic asthma: This is the first study to demonstrate that treatment with LOL effectively attenuates airway inflammation, mucus hypersecretion, and ROS-mediated oxidative stress in the OVA-challenged allergic asthma model and TNF-α-stimulated NCI-H292 cell.